144	207	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(0, 0), 'end':(0, 0), 'text':'Discussion'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(1, 0), 'end':(1, 5), 'text':'Introduction of Ras ( V12 )'}, {'start':(1, 6), 'end':(1, 12), 'text':'into immortalized MCF10As transforms these cells .'}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(2, 0), 'end':(2, 2), 'text':'We demonstrate here'}, {'start':(2, 3), 'end':(2, 22), 'text':'that Ras ( V12 ) introduction into MCF10As and subsequent transformation is accompanied by degradation of C and EBPbeta1 .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(3, 0), 'end':(3, 1), 'text':'We show'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'background', 'direction':'LeftToRight', 'children':[{'start':(3, 2), 'end':(3, 2), 'text':'that'}, {'start':(3, 3), 'end':(3, 14), 'text':'when T7-C and EBPbeta1 is expressed in MCF10A and MCF10A-Ras cells ,'}]}, {'start':(3, 15), 'end':(3, 22), 'text':'MCF10A-C and EBPbeta1 cells maintain expression of p52-T7-C'}]}, {'start':(3, 23), 'end':(3, 25), 'text':'/ EBPbeta1 ,'}]}, {'start':(3, 26), 'end':(3, 31), 'text':'whereas MCF10A-Ras cells degrade p52-T7-C /'}]}, {'start':(3, 32), 'end':(3, 33), 'text':'EBPbeta1 .'}]}]}, {'start':(4, 0), 'end':(4, 15), 'text':'Stability of C and EBPbeta1 expression may be regulated by ubiquitin dependent degradation ( ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(5, 0), 'end':(5, 4), 'text':'It has been previously demonstrated'}, {'start':(5, 5), 'end':(5, 29), 'text':'that p52-C and EBPbeta1 is expressed in normal mammary epithelial tissue and cultured normal MECs , but not in breast cancer cells ( ) .'}]}, {'start':(6, 0), 'end':(6, 9), 'text':'The Ras pathway is activated in most breast cancers .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 27), 'text':'Expression of T7-C and EBPbeta1 in the breast cancer cell lines MDA231 and MDA435 decreased over time , similar to T7-C and EBPbeta1 expression in MCF10A-Ras cells .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 0), 'end':(8, 17), 'text':'Additionally , treatment of MDA231- and MDA435-C and EBPbeta1 cells with a proteasomal inhibitor stabilized expression of p52-T7-C'}, {'start':(8, 18), 'end':(8, 20), 'text':'/ EBPbeta1 .'}]}, {'start':(9, 0), 'end':(9, 20), 'text':'Therefore it is likely that C and EBPbeta1 is negatively regulated in breast cancer through activation of the Ras pathway .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 0), 'end':(10, 14), 'text':'C and EBPbeta is phosphorylated by a number of kinases in the Ras pathway .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(11, 0), 'end':(11, 13), 'text':'Therefore we treated the MCF10A-Ras-C and EBPbeta1 cells with a panel of kinase inhibitors'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(11, 14), 'end':(11, 15), 'text':'to determine'}, {'start':(11, 16), 'end':(11, 25), 'text':'if inhibiting phosphorylation could stabilize p52-C and EBPbeta1 expression .'}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(12, 0), 'end':(12, 1), 'text':'We found'}, {'start':(12, 2), 'end':(12, 14), 'text':'that treatment with the cdk inhibitor roscovitine stabilized C and EBPbeta1 expression .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 0), 'end':(13, 5), 'text':'Ras activation activates cdk2 ( ;'}, {'start':(13, 6), 'end':(13, 9), 'text':'reviewed in ) .'}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(14, 0), 'end':(14, 4), 'text':'Two independent groups have demonstrated'}, {'start':(14, 5), 'end':(14, 16), 'text':'that C and EBPbeta can be phosphorylated on Thr235 by cdk2 .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(15, 0), 'end':(15, 10), 'text':'This phosphorylation is specific to the cdk family member cdk2 ,'}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(15, 11), 'end':(15, 11), 'text':'and'}, {'start':(15, 12), 'end':(15, 26), 'text':'when cells are treated with roscovitine there is a decrease in phosphorylation of Thr235 .'}]}]}, {'start':(16, 0), 'end':(16, 13), 'text':'Additionally , knockdown of cdk2 decreases phosphorylation of C and EBPbetaThr235 ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'LeftToRight', 'children':[{'start':(17, 0), 'end':(17, 12), 'text':'The non phosphorylatable C and EBPbeta1T235A could be stably expressed in MCF10A-Ras cells'}, {'start':(17, 13), 'end':(17, 21), 'text':'as compared to wild type C and EBPbeta1 .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(18, 0), 'end':(18, 13), 'text':'Therefore , activation of the Ras pathway in MECs negatively regulates C and EBPbeta1'}, {'label':'joint', 'direction':'None', 'children':[{'start':(18, 14), 'end':(18, 24), 'text':'by promoting phosphorylation of C and EBPbeta1 on Thr235 by cdk2'}, {'start':(18, 25), 'end':(18, 34), 'text':'and subsequently leading to degradation of C and EBPbeta1 .'}]}]}, {'start':(19, 0), 'end':(19, 9), 'text':'Loss of T7-C and EBPbeta1 does take several days .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(20, 0), 'end':(20, 11), 'text':'This may be due to an initial compensatory mechanism by the cell'}, {'start':(20, 12), 'end':(20, 41), 'text':'leading to increased synthesis of C and EBPbeta1 and and or a requirement for expression of a specific ubiquitin E3 ligase necessary for the degradation of C and EBPbeta1 .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(21, 0), 'end':(21, 15), 'text':'Although introduction of Ras ( V12 ) into many immortalized cell lines leads to transformation ,'}, {'start':(21, 16), 'end':(21, 29), 'text':'introduction of Ras ( V12 ) into primary cells has a different effect .'}]}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(22, 0), 'end':(22, 9), 'text':'Normal fibroblasts , such as WI-38 HDFs , undergo senescence'}, {'start':(22, 10), 'end':(22, 27), 'text':'when forced to express oncogenes such as activated Ras ( V12 ) or Raf ( E600 ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(23, 0), 'end':(23, 0), 'text':'demonstrated'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(23, 1), 'end':(23, 8), 'text':'that C and EBPbeta is necessary for Ras'}, {'start':(23, 9), 'end':(23, 17), 'text':'( V12 ) - induced senescence in MEFs ,'}]}, {'start':(23, 18), 'end':(23, 25), 'text':'which occurred in a pRB dependent manner .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(24, 0), 'end':(24, 2), 'text':'Recently has shown'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(24, 3), 'end':(24, 11), 'text':'that C and EBPbeta is required for activated Raf'}, {'start':(24, 12), 'end':(24, 20), 'text':'( E600 ) - induced senescence in HDFs .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'evaluation', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(25, 0), 'end':(25, 3), 'text':'In the present study'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(25, 4), 'end':(25, 8), 'text':'we set out to determine'}, {'start':(25, 9), 'end':(25, 20), 'text':'which transactivator isoform of C and EBPbeta is responsible for OIS ,'}]}]}, {'start':(25, 21), 'end':(25, 43), 'text':'as there is increasing evidence for functional differences between the transactivator isoforms ( , , , Kowentz-Leutz and Leutz , 1999 ) .'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(26, 0), 'end':(26, 2), 'text':'First we demonstrate'}, {'start':(26, 3), 'end':(26, 16), 'text':'that C and EBPbeta1 is not degraded in senescing WI-38-Ras cells ( ) .'}]}]}, {'start':(27, 0), 'end':(27, 16), 'text':'This is because cdk2 is not activated in these cells due to activation of cdk inhibitors .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(28, 0), 'end':(28, 0), 'text':'demonstrated'}, {'start':(28, 1), 'end':(28, 11), 'text':'that C and EBPbeta induced senescence through induction of IL6 .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(29, 0), 'end':(29, 1), 'text':'We show'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(29, 2), 'end':(29, 13), 'text':'that it is the full length isoform , C and EBPbeta1 ,'}, {'start':(29, 14), 'end':(29, 22), 'text':'that is able to robustly induce IL6 expression .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(30, 0), 'end':(30, 3), 'text':'Accordingly , we demonstrate'}, {'start':(30, 4), 'end':(30, 17), 'text':'that C and EBPbeta1 is the strongest inducer of senescence in WI-38 fibroblasts .'}]}, {'start':(31, 0), 'end':(31, 10), 'text':'C and EBPbeta2 can induce senescence to a lesser extent .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(32, 0), 'end':(32, 2), 'text':'It is interesting'}, {'start':(32, 3), 'end':(32, 14), 'text':'that C and EBPbeta2 expression in WI-38 fibroblasts does induce senescence .'}]}, {'label':'explanation', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(33, 0), 'end':(33, 10), 'text':'Because C and EBPbeta1 is expressed in the WI-38 cells ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(33, 11), 'end':(33, 15), 'text':'we can not rule out'}, {'start':(33, 16), 'end':(33, 40), 'text':'that C and EBPbeta2 is heterodimerizing with the endogenous C and EBPbeta1 to induce IL6 and thus senescence , albeit at a lower level .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(34, 0), 'end':(34, 17), 'text':'Whether as a heterodimer or homodimer , C and EBPbeta2 may be upregulating the expression of other factors'}, {'start':(34, 18), 'end':(34, 21), 'text':'involved in OIS .'}]}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(35, 0), 'end':(35, 2), 'text':'Taken together ,'}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(35, 3), 'end':(35, 21), 'text':'it is likely that Ras ( V12 ) / Raf ( E600 ) is working through C and EBPbeta1'}, {'label':'joint', 'direction':'None', 'children':[{'start':(35, 22), 'end':(35, 24), 'text':'to induce IL6'}, {'start':(35, 25), 'end':(35, 32), 'text':'and lead to senescence in normal cells .'}]}]}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(36, 0), 'end':(36, 1), 'text':'We propose'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(36, 2), 'end':(36, 16), 'text':'that degradation of C and EBPbeta1 by Ras ( V12 ) may be a mechanism'}, {'start':(36, 17), 'end':(36, 22), 'text':'by which cells bypass OIS .'}]}]}, {'start':(37, 0), 'end':(37, 22), 'text':'Loss of expression of full length C and EBPbeta1 may be necessary for escape from senescence and a step closer to transformation .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(38, 0), 'end':(38, 18), 'text':'Further support of this lies in the expression profile of C and EBPbeta1 in normal versus transformed cells .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(39, 0), 'end':(39, 8), 'text':'C and EBPbeta1 is present in normal cells ,'}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(39, 9), 'end':(39, 12), 'text':'and is not degraded'}, {'start':(39, 13), 'end':(39, 28), 'text':'when Ras ( V12 ) is introduced and induces senescence in normal cells ( ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(40, 0), 'end':(40, 15), 'text':'Additionally , this first isoform of C and EBPbeta is negatively regulated by Ras during Ras'}, {'start':(40, 16), 'end':(40, 24), 'text':'( V12 ) transformation of MCF10As ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(41, 0), 'end':(41, 10), 'text':'p52-C and EBPbeta1 expression is not observed in breast cancer cells'}, {'start':(41, 11), 'end':(41, 18), 'text':'in which the Ras pathway is activated .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(42, 0), 'end':(42, 15), 'text':'The expression pattern of C and EBPbeta1 in normal versus transformed cells supports our current findings'}, {'label':'joint', 'direction':'None', 'children':[{'start':(42, 16), 'end':(42, 25), 'text':'that C and EBPbeta1 plays an important role in senescence'}, {'start':(42, 26), 'end':(42, 32), 'text':'and is negatively regulated during transformation .'}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(43, 0), 'end':(43, 3), 'text':'It is not surprising'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(43, 4), 'end':(43, 6), 'text':'that a protein'}, {'start':(43, 7), 'end':(43, 25), 'text':'that plays a critical role in OIS , a tumor suppressive mechanism , be down regulated during transformation .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'None', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(44, 0), 'end':(44, 6), 'text':'Moreover , recently it has been shown'}, {'start':(44, 7), 'end':(44, 12), 'text':'that cdk2 suppresses cellular senescence ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(44, 13), 'end':(44, 16), 'text':'consistent with our findings'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(44, 17), 'end':(44, 30), 'text':'that inhibiting cdk2 with roscovitine stabilizes expression of C and EBPbeta1 , a factor'}, {'start':(44, 31), 'end':(44, 38), 'text':'involved in senescence ( Campaner et al. ,'}]}, {'start':(44, 39), 'end':(44, 43), 'text':'Hydbring et al. ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(45, 0), 'end':(45, 12), 'text':'In further support of our findings , used a C and EBPbeta construct'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(45, 13), 'end':(45, 25), 'text':'in which the start sites for C and EBPbeta2 and -3 were mutated'}, {'start':(45, 26), 'end':(45, 35), 'text':'such that only C and EBPbeta1 could be translated .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(46, 0), 'end':(46, 1), 'text':'They demonstrated'}, {'start':(46, 2), 'end':(46, 23), 'text':'that expression of this construct in HDFs led to cell cycle arrest and induction of IL6 , consistent with our results .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(47, 0), 'end':(47, 12), 'text':'The production of multiple isoforms of C and EBPbeta is a possible explanation'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(47, 13), 'end':(47, 22), 'text':'for which this transcription factor could regulate the functional differences'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(47, 23), 'end':(47, 27), 'text':'observed upon expression of Ras'}, {'start':(47, 28), 'end':(47, 31), 'text':'( V12 ) .'}]}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(48, 0), 'end':(48, 2), 'text':'Our data indicate'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(48, 3), 'end':(48, 13), 'text':'that C and EBPbeta1 is the isoform responsible for mediating Ras'}, {'start':(48, 14), 'end':(48, 20), 'text':'( V12 ) - induced senescence .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(49, 0), 'end':(49, 19), 'text':'In contrast to C and EBPbeta1 , C and EBPbeta2 expression is not negatively regulated in MCF10A cells upon Ras'}, {'start':(49, 20), 'end':(49, 22), 'text':'( V12 )'}]}, {'start':(49, 23), 'end':(49, 28), 'text':'- induced transformation ( ) .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(50, 0), 'end':(50, 29), 'text':'Additionally , overexpression of C and EBPbeta2 in MCF10As leads to the acquisition of tumorigenic characteristics ( ) , similarly to Ras ( V12 ) expression in these cells .'}, {'start':(51, 0), 'end':(51, 16), 'text':'Therefore , Ras may be signaling to this second isoform of C and EBPbeta during transformation .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(52, 0), 'end':(52, 16), 'text':'Unfortunately it is not possible to knockdown each specific isoform of C and EBPbeta via siRNA technology'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(52, 17), 'end':(52, 20), 'text':'and determine the role'}, {'label':'explanation', 'direction':'LeftToRight', 'children':[{'start':(52, 21), 'end':(52, 25), 'text':'each isoform is playing ,'}, {'start':(52, 26), 'end':(52, 37), 'text':'because all three isoforms are translated from a single mRNA molecule .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(53, 0), 'end':(53, 15), 'text':'Importantly , one study has examined the specific role of C and EBPbeta2 in activated macrophages'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(53, 16), 'end':(53, 20), 'text':'by generating a knock-in mouse'}, {'start':(53, 21), 'end':(53, 41), 'text':'in which the second in-frame methionine necessary for translation of C and EBPbeta2 was replaced with an alanine ( ) .'}]}]}, {'start':(54, 0), 'end':(54, 10), 'text':'This abolished expression of C and EBPbeta2 in these mice .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(55, 0), 'end':(55, 18), 'text':'The induction of C and EBPbeta target genes , such as IL6 , was examined in this study .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(56, 0), 'end':(56, 23), 'text':'Activated macrophages in the mice unable to express C and EBPbeta2 were still able to induce IL6 expression , consistent with our current findings'}, {'start':(56, 24), 'end':(56, 40), 'text':'that C and EBPbeta2 is not the primary isoform responsible for induction of IL6 in HDFs .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(57, 0), 'end':(57, 12), 'text':'C and EBPbeta plays many functional roles in the cell , even roles'}, {'start':(57, 13), 'end':(57, 30), 'text':'that seem conflicting such as cell survival , cell death , proliferation , senescence , and transformation .'}]}, {'start':(58, 0), 'end':(58, 21), 'text':'This may be explained in part by the presence of the different isoforms of C and EBPbeta and their functional differences .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(59, 0), 'end':(59, 11), 'text':'Future studies on C and EBPbeta will need to take into consideration'}, {'start':(59, 12), 'end':(59, 26), 'text':'that the different isoforms of this transcription factor are likely playing functionally distinct roles .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(60, 0), 'end':(60, 13), 'text':'Degradation of C and EBPbeta1 by Ras ( V12 ) may be a mechanism'}, {'start':(60, 14), 'end':(60, 19), 'text':'by which cells bypass OIS .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(61, 0), 'end':(61, 11), 'text':'Our study sheds light on how Ras signaling is altered in Ras'}, {'start':(61, 12), 'end':(61, 45), 'text':'( V12 ) - induced senescence versus transformation through the regulation of C and EBPbeta1 , however further investigation of what dictates this transition is necessary to more completely understand this critical switch .'}]}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(62, 0), 'end':(62, 19), 'text':'It will be important to determine the details of the signaling between Ras and C and EBPbeta in normal cells'}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(62, 20), 'end':(62, 22), 'text':'to elucidate mechanisms'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(62, 23), 'end':(62, 27), 'text':'by which this critical signaling'}, {'start':(62, 28), 'end':(62, 39), 'text':'that induces OIS can be triggered or maintained to suppress tumorigenesis .'}]}]}]}]}]}]}]}]}]}]}]}
14	69	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(0, 0), 'end':(0, 0), 'text':'Introduction'}, {'label':'joint', 'direction':'None', 'children':[{'start':(1, 0), 'end':(1, 7), 'text':'Ras signaling leads to proliferation and cell survival'}, {'start':(1, 8), 'end':(1, 14), 'text':'and is activated in many cancers .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 11), 'text':'Aberrant function of the Ras pathway is very common in breast cancers'}, {'start':(2, 12), 'end':(2, 17), 'text':'( reviewed in , ) .'}]}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 12), 'text':'Introduction of activated Ras ( V12 ) into most immortalized cell lines ,'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 13), 'end':(3, 20), 'text':'including the immortalized MCF10A human mammary epithelial cell'}, {'start':(3, 21), 'end':(3, 25), 'text':'( HMEC ) line ,'}]}, {'start':(3, 26), 'end':(3, 29), 'text':'leads to transformation .'}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(4, 0), 'end':(4, 1), 'text':'However ,'}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(4, 2), 'end':(4, 12), 'text':'when Ras ( V12 ) is expressed in primary cells ,'}, {'start':(4, 13), 'end':(4, 20), 'text':'these cells senesce instead of undergoing transformation .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 0), 'end':(5, 6), 'text':'This oncogene induced senescence ( OIS )'}, {'start':(5, 7), 'end':(5, 20), 'text':'displayed by primary cells represents a tumor suppressive mechanism inherent in these cells .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 0), 'end':(6, 8), 'text':'Research is ongoing to determine the proteins and pathways'}, {'start':(6, 9), 'end':(6, 12), 'text':'involved in Ras transformation'}]}, {'start':(6, 13), 'end':(6, 17), 'text':'and Ras induced senescence .'}]}, {'label':'cause', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 17), 'text':'It is important to determine the different molecular players necessary for Ras transformation versus Ras induced senescence ,'}, {'start':(7, 18), 'end':(7, 27), 'text':'as these could be critical targets for cancer therapy .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 0), 'end':(8, 27), 'text':'C and EBPbeta , an essential downstream mediator of both Ras transformation ( ) and activated Ras and Raf ( a downstream mediator of Ras signaling ) -'}, {'start':(8, 28), 'end':(8, 30), 'text':'induced senescence ,'}]}, {'start':(8, 31), 'end':(8, 52), 'text':'is a member of the CCAAT and enhancer binding protein ( C and EBP ) family of basic leucine-zipper transcription factors .'}]}, {'start':(9, 0), 'end':(9, 17), 'text':'Three protein isoforms of C and EBPbeta exist due to alternative translation initiation at three in-frame methionines .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(10, 0), 'end':(10, 12), 'text':'In humans , full-length C and EBPbeta1 begins at the first in-frame ATG'}, {'start':(10, 13), 'end':(10, 21), 'text':'and has an apparent molecular weight of 52kDa .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(11, 0), 'end':(11, 16), 'text':'C and EBPbeta2 begins at the second in-frame methionine , 23 amino acids downstream from the first'}, {'start':(11, 17), 'end':(11, 28), 'text':'and appears as a doublet on immunoblots at 45kDa and 48kDa .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(12, 0), 'end':(12, 12), 'text':'C and EBPbeta3 begins at the last in-frame ATG at amino acid 198'}, {'start':(12, 13), 'end':(12, 21), 'text':'and has an apparent molecular weight of 20kDa .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 0), 'end':(13, 21), 'text':'C and EBPbeta1 and C and EBPbeta2 both contain the C-terminal DNA binding and dimerization domain and an N-terminal transactivation domain ,'}, {'start':(13, 22), 'end':(13, 29), 'text':'allowing them to function as transcriptional activators .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(14, 0), 'end':(14, 7), 'text':'C and EBPbeta3 lacks the N-terminal transactivation domain'}, {'start':(14, 8), 'end':(14, 14), 'text':'and thus represses transcription ( ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(15, 0), 'end':(15, 6), 'text':'The C and EBPbeta knockout mouse demonstrated'}, {'start':(15, 7), 'end':(15, 20), 'text':'that C and EBPbeta is essential for proper development of the mammary gland .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 0), 'end':(16, 6), 'text':'These mice display a dual phenotype :'}, {'start':(16, 7), 'end':(16, 14), 'text':'a defect in MEC proliferation and differentiation .'}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(17, 0), 'end':(17, 10), 'text':'The production of multiple isoforms of C and EBPbeta may explain'}, {'start':(17, 11), 'end':(17, 22), 'text':'how a single transcription factor can regulate both differentiation and proliferation .'}]}]}, {'label':'contrast', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 0), 'end':(18, 18), 'text':'The functional differences between the transactivator isoforms of C and EBPbeta have not been studied in great detail .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(19, 0), 'end':(19, 21), 'text':'C and EBPbeta1 is oftentimes mistaken for the 48 kDa ( top band ) of the C and EBPbeta2 doublet on immunoblots'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(19, 22), 'end':(19, 33), 'text':'largely because C and EBPbeta1 is not expressed in transformed cell lines'}, {'start':(19, 34), 'end':(19, 38), 'text':'( see below ) .'}]}]}]}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(20, 0), 'end':(20, 3), 'text':'Because of this difficulty'}, {'start':(20, 4), 'end':(20, 11), 'text':'in deciphering between C and EBPbeta1 and -2'}]}, {'start':(20, 12), 'end':(20, 27), 'text':'and because both isoforms are transcriptional activators , many consider them to be functionally redundant .'}]}, {'start':(21, 0), 'end':(21, 16), 'text':'However , recent studies indicate C and EBPbeta1 and -2 both play unique and important roles .'}]}]}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(22, 0), 'end':(22, 32), 'text':'For example , C and EBPbeta1 but not C and EBPbeta2 cooperates with c-Myb to transactivate differentiation genes in myeloid cells via the ability of C and EBPbeta1 , but not -2 ,'}, {'start':(22, 33), 'end':(22, 44), 'text':'to recruit the SWI and SNF chromatin remodeling complex ( ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(23, 0), 'end':(23, 17), 'text':'Additionally , C and EBPbeta1 but not C and EBPbeta2 can be modified by the post-translational modification SUMO-2'}, {'start':(23, 18), 'end':(23, 22), 'text':'/ 3 ( ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(24, 0), 'end':(24, 21), 'text':'Furthermore , a striking difference exists in the expression profiles of C and EBPbeta1 and -2 in normal versus tumorigenic HMECs .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(25, 0), 'end':(25, 11), 'text':'C and EBPbeta1 is found in normal MECs from reduction mammoplasties ,'}, {'start':(25, 12), 'end':(25, 18), 'text':'whereas C and EBPbeta2 is not .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(26, 0), 'end':(26, 15), 'text':'Moreover , a majority of human breast tumors express significant levels of C and EBPbeta2 .'}, {'start':(27, 0), 'end':(27, 2), 'text':'( ) .'}]}]}]}, {'label':'contrast', 'direction':'None', 'children':[{'start':(28, 0), 'end':(28, 10), 'text':'C and EBPbeta2 is expressed in breast cancer cell lines ,'}, {'start':(28, 11), 'end':(28, 17), 'text':'while p52-C and EBPbeta1 is not .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(29, 0), 'end':(29, 2), 'text':'Further investigation indicated'}, {'start':(29, 3), 'end':(29, 11), 'text':'that these distinct expression profiles have functional significance .'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(30, 0), 'end':(30, 9), 'text':'C and EBPbeta2 , but not C and EBPbeta1 ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(30, 10), 'end':(30, 27), 'text':'can transactivate cyclin D1 ( ) and PLAC1 ( Koslwski et al. , 2009 ) , two genes'}, {'start':(30, 28), 'end':(30, 41), 'text':'whose protein products are involved in proliferation and commonly upregulated in breast cancer .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(31, 0), 'end':(31, 22), 'text':'Furthermore , C and EBPbeta2 , but not C and EBPbeta1 , over-expression in MCF10A MECs transforms this cell line ( ) .'}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(32, 0), 'end':(32, 2), 'text':'Taken together ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(32, 3), 'end':(32, 5), 'text':'these data suggest'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(32, 6), 'end':(32, 21), 'text':'that C and EBPbeta1 and -2 are functionally distinct in MECs , with C and EBPbeta1'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(32, 22), 'end':(32, 32), 'text':'playing a role in non proliferating MECs and C and EBPbeta2'}, {'start':(32, 33), 'end':(32, 39), 'text':'promoting proliferation and other transforming characteristics .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(33, 0), 'end':(33, 12), 'text':'Since C and EBPbeta is an essential downstream mediator of Ras signaling ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(33, 13), 'end':(33, 26), 'text':'the production of multiple isoforms of C and EBPbeta may be a potential mechanism'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(33, 27), 'end':(33, 31), 'text':'to explain the functional differences'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(33, 32), 'end':(33, 36), 'text':'observed upon expression of Ras'}, {'start':(33, 37), 'end':(33, 40), 'text':'( V12 ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(34, 0), 'end':(34, 13), 'text':'C and EBPbeta is crucial for both Ras transformation and Ras induced senescence .'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(35, 0), 'end':(35, 0), 'text':'reported'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(35, 1), 'end':(35, 18), 'text':'that v-Ha-ras transgenic mice deficient for C and EBPbeta had smaller and fewer skin tumors than v-Ha-ras mice'}, {'start':(35, 19), 'end':(35, 24), 'text':'that expressed C and EBPbeta .'}]}]}]}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(36, 0), 'end':(36, 2), 'text':'They also demonstrated'}, {'start':(36, 3), 'end':(36, 18), 'text':'that C and EBPbeta cooperates with Ras ( V12 ) in transformation of NIH-3T3 cells .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(37, 0), 'end':(37, 10), 'text':'Recently , C and EBPbeta has been shown to be necessary'}, {'start':(37, 11), 'end':(37, 17), 'text':'for Ras induced senescence ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(38, 0), 'end':(38, 19), 'text':'Additionally , activation of interleukin-6 ( IL6 ) by C and EBPbeta is essential for activated Raf ( E600 )'}, {'start':(38, 20), 'end':(38, 25), 'text':'- induced senescence ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(39, 0), 'end':(39, 10), 'text':'C and EBPbeta is phosphorylated in response to Ras signaling ,'}, {'start':(39, 11), 'end':(39, 23), 'text':'and this phosphorylation is oftentimes critical for the Ras induced phenotype observed .'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(40, 0), 'end':(40, 5), 'text':'A residue in C and EBPbeta'}, {'start':(40, 6), 'end':(40, 11), 'text':'that is frequently phosphorylated upon Ras'}]}, {'start':(40, 12), 'end':(40, 33), 'text':'( V12 ) introduction is threonine 235 ( Thr235 ) in humans ( Thr189 in rat , Thr188 in mouse ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(41, 0), 'end':(41, 0), 'text':'revealed'}, {'start':(41, 1), 'end':(41, 24), 'text':'that Ras ( V12 ) expression in NIH-3T3s enhanced phosphorylation of Thr189 in C and EBPbeta by cyclin dependent kinase-2 ( cdk2 ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(42, 0), 'end':(42, 31), 'text':'Additionally , this site in C and EBPbeta2 is necessary for the Ras stimulated interaction of C and EBPbeta2 and serum response factor for transactivation of serum response element in NIH-3T3 cells'}, {'start':(42, 32), 'end':(42, 42), 'text':'and was shown to be phosphorylated by Erk-2 ( ) .'}]}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(43, 0), 'end':(43, 3), 'text':'As mentioned earlier ,'}, {'start':(43, 4), 'end':(43, 14), 'text':'transformed cell lines typically do not express p52-C and EBPbeta1 .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(44, 0), 'end':(44, 19), 'text':'However , the immortal but non transformed HMEC line , MCF10A , expresses all three C and EBPbeta isoforms .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(45, 0), 'end':(45, 6), 'text':'In the current study , we demonstrate'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(45, 7), 'end':(45, 7), 'text':'that'}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(45, 8), 'end':(45, 17), 'text':'when Ras ( V12 ) is introduced into MCF10As ,'}, {'start':(45, 18), 'end':(45, 27), 'text':'transformation is accompanied by degradation of p52-C and EBPbeta1 .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(46, 0), 'end':(46, 3), 'text':'Treatment of MCF10A-Ras cells'}, {'start':(46, 4), 'end':(46, 19), 'text':'forced to express C and EBPbeta1 with the cdk inhibitor roscovitine stabilizes p52-C and EBPbeta1 .'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(47, 0), 'end':(47, 4), 'text':'It has been previously shown'}, {'start':(47, 5), 'end':(47, 13), 'text':'that cdk2 phosphorylates C and EBPbeta on Thr235 .'}]}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(48, 0), 'end':(48, 1), 'text':'We demonstrate'}, {'start':(48, 2), 'end':(48, 25), 'text':'that mutation of Thr235 to alanine in C and EBPbeta1 is sufficient to restore stability of p52-C and EBPbeta1 expression in MCF10A-Ras cells .'}]}]}, {'label':'background', 'direction':'RightToLeft', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(49, 0), 'end':(49, 2), 'text':'Since we observed'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(49, 3), 'end':(49, 19), 'text':'that Ras ( V12 ) negatively regulates C and EBPbeta1 in immortalized MCF10As , a cell line'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(49, 20), 'end':(49, 26), 'text':'that escapes senescence upon introduction of Ras'}, {'start':(49, 27), 'end':(49, 30), 'text':'( V12 ) ,'}]}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(49, 31), 'end':(49, 33), 'text':'and we know'}, {'start':(49, 34), 'end':(49, 51), 'text':'that Ras ( V12 ) induces senescence in a C and EBPbeta dependent manner in normal cells ,'}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(49, 52), 'end':(49, 55), 'text':'we decided to examine'}, {'start':(49, 56), 'end':(49, 65), 'text':'whether C and EBPbeta1 was able to induce senescence .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(50, 0), 'end':(50, 14), 'text':'Induction of IL6 by C and EBPbeta is critical for activated Raf ( E600 )'}, {'start':(50, 15), 'end':(50, 20), 'text':'- induced senescence ( ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(51, 0), 'end':(51, 9), 'text':'When C and EBPbeta -1 and -2 are compared ,'}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(51, 10), 'end':(51, 18), 'text':'only full length C and EBPbeta1 strongly upregulates IL6'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(51, 19), 'end':(51, 26), 'text':'when introduced into the normal human diploid fibroblasts'}, {'start':(51, 27), 'end':(51, 32), 'text':'( HDFs ) , WI-38 .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(52, 0), 'end':(52, 2), 'text':'Additionally we show'}, {'start':(52, 3), 'end':(52, 17), 'text':'that C and EBPbeta1 is a more potent inducer of senescence in these cells .'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(53, 0), 'end':(53, 2), 'text':'Our results indicate'}, {'label':'joint', 'direction':'None', 'children':[{'start':(53, 3), 'end':(53, 14), 'text':'that C and EBPbeta1 is negatively regulated by Ras ( V12 )'}, {'label':'joint', 'direction':'None', 'children':[{'start':(53, 15), 'end':(53, 17), 'text':'in immortalized MCF10As'}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(53, 18), 'end':(53, 33), 'text':'and this full length C and EBPbeta isoform is able to induce senescence in WI-38 cells'}, {'start':(53, 34), 'end':(53, 37), 'text':'by inducing IL6 .'}]}]}]}]}]}]}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(54, 0), 'end':(54, 2), 'text':'Taken together ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(54, 3), 'end':(54, 14), 'text':'degradation of C and EBPbeta1 by Ras activation may represent a mechanism'}, {'start':(54, 15), 'end':(54, 18), 'text':'to bypass OIS .'}]}]}]}]}]}]}]}]}
0	1	{'start':(0, 0), 'end':(0, 21), 'text':'Regulation of C and EBPbeta1 by Ras in mammary epithelial cells and the role of C and EBPbeta1 in oncogene induced senescence'}
243	244	{'start':(0, 0), 'end':(0, 0), 'text':'3'}
240	241	{'start':(0, 0), 'end':(0, 1), 'text':'Supplementary Material'}
1	14	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(0, 0), 'end':(0, 16), 'text':'Overexpression of Ras ( V12 ) in MCF10A cells , an immortalized mammary epithelial cell line ,'}, {'start':(0, 17), 'end':(0, 23), 'text':'leads to transformation of these cells .'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(1, 0), 'end':(1, 1), 'text':'We demonstrate'}, {'start':(1, 2), 'end':(1, 12), 'text':'that this is accompanied by degradation of C and EBPbeta1 .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 6), 'text':'C and EBPbeta is a transcription factor'}, {'start':(2, 7), 'end':(2, 21), 'text':'in which three protein isoforms exist due to alternative translation at three in-frame methionines .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(3, 0), 'end':(3, 12), 'text':'When C and EBPbeta1 is expressed in MCF10A-Ras ( V12 ) cells ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(3, 13), 'end':(3, 15), 'text':'immunoblot analysis reveals'}, {'start':(3, 16), 'end':(3, 25), 'text':'that C and EBPbeta1 is degraded in these cells .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 24), 'text':'Treatment of the MCF10A-Ras ( V12 ) - C and EBPbeta1 cells with the cdk inhibitor roscovitine leads to stabilization of C and EBPbeta1 .'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(5, 0), 'end':(5, 4), 'text':'It has been previously shown'}, {'start':(5, 5), 'end':(5, 13), 'text':'that cdk2 phosphorylates C and EBPbeta on Thr235 .'}]}]}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(6, 0), 'end':(6, 1), 'text':'We demonstrate'}, {'start':(6, 2), 'end':(6, 30), 'text':'that mutation of Thr235 to alanine in C and EBPbeta1 is sufficient to restore the stability of C and EBPbeta1 expression in the MCF10A-Ras ( V12 ) cells .'}]}]}, {'label':'cause', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 14), 'text':'Overexpression of Ras ( V12 ) in primary cells induces senescence rather than transformation ,'}, {'start':(7, 15), 'end':(7, 18), 'text':'thus suppressing tumorigenesis .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 0), 'end':(8, 17), 'text':'C and EBPbeta is required for Ras ( V12 ) - induced senescence in primary mouse embryonic fibroblasts'}, {'start':(8, 18), 'end':(8, 21), 'text':'( MEFs ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 0), 'end':(9, 12), 'text':'Upregulation of IL6 by C and EBPbeta has been shown to be necessary'}, {'start':(9, 13), 'end':(9, 17), 'text':'for oncogene induced senescence ,'}]}, {'start':(9, 18), 'end':(9, 30), 'text':'but the specific isoform of C and EBPbeta has not been investigated .'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(10, 0), 'end':(10, 1), 'text':'We show'}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(10, 2), 'end':(10, 9), 'text':'that the C and EBPbeta1 isoform upregulates IL6'}, {'start':(10, 10), 'end':(10, 15), 'text':'when introduced into normal fibroblasts .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(11, 0), 'end':(11, 3), 'text':'Additionally , we show'}, {'start':(11, 4), 'end':(11, 10), 'text':'that C and EBPbeta1 induces senescence .'}]}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(12, 0), 'end':(12, 2), 'text':'Taken together ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 3), 'end':(12, 14), 'text':'degradation of C and EBPbeta1 by Ras activation may represent a mechanism'}, {'start':(12, 15), 'end':(12, 18), 'text':'to bypass OIS .'}]}]}]}]}]}]}]}
207	240	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 2), 'text':'Materials and Methods'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 1), 'text':'Cell lines'}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 9), 'text':'HMECs , MCF10A , MDA231 , and MDA435 were maintained'}, {'start':(2, 10), 'end':(2, 13), 'text':'as described previously .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 23), 'text':'The WI-38 cells ( a gift from the Dr. Hal Moses lab , Vanderbilt University ) were maintained in Eagle \'s minimal essential medium'}, {'start':(3, 24), 'end':(3, 40), 'text':'supplemented with 10 % fetal bovine serum ( HyClone Laboratories Logan , UT , USA ) ,'}]}, {'start':(3, 41), 'end':(3, 63), 'text':'100U and mL penicillin , and 100ug and mL streptomycin ( Life Technologies , Inc. , Carlsbad , CA , USA ) .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(4, 0), 'end':(4, 25), 'text':'The phoenix-ampho packaging cell line was obtained from the ATCC with the permission of GP Nolan ( Stanford University , Palo Alto , CA ) ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(4, 26), 'end':(4, 31), 'text':'has been previously described ( )'}, {'start':(4, 32), 'end':(4, 46), 'text':'and were maintained as described previously ( Bundy and Sealy , et al. ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 0), 'end':(5, 7), 'text':'Cloning of recombinant retroviral constructs and virus preparation'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(6, 0), 'end':(6, 5), 'text':'Generation of LZRS-T7-C / EBPbeta1-IRES-eGFP was'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 6), 'end':(6, 8), 'text':'as follows :'}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(6, 9), 'end':(6, 17), 'text':'IRES-eGFP-LZRS and T7-C and EBPbeta1-pcDNA 3.1-His A was generated'}, {'start':(6, 18), 'end':(6, 21), 'text':'as described previously .'}]}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(7, 0), 'end':(7, 9), 'text':'T7-C and EBPbeta1-pcDNA 3.1 was digested with EcoRI and NotI'}, {'start':(7, 10), 'end':(7, 16), 'text':'and incubated with DNA Polymerase I .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 0), 'end':(8, 10), 'text':'The resulting T7-C and EBPbeta1 insert was ligated into LZRS-IRES-eGFP ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(8, 11), 'end':(8, 18), 'text':'which had been digested with EcoRI and BamHI'}, {'start':(8, 19), 'end':(8, 25), 'text':'and incubated with DNA Polymerase I .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 0), 'end':(9, 2), 'text':'This generated LZRS-T7-C'}, {'start':(9, 3), 'end':(9, 5), 'text':'/ EBPbeta1-IRES-eGFP .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'LeftToRight', 'children':[{'start':(10, 0), 'end':(10, 4), 'text':'LZRS-T7-C / EBPbeta1T235A-IRES-eGFP was generated'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 5), 'end':(10, 7), 'text':'as follows :'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 8), 'end':(10, 24), 'text':'NF-IL6T235A-CMV , a generous gift from the Akira laboratory , and our C and EBPbeta1-pRSET-A construct ,'}, {'start':(10, 25), 'end':(10, 33), 'text':'described in were digested with MscI and BbsI .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 0), 'end':(11, 8), 'text':'The T235A fragment was ligated into C and EBPbeta1-pRSET-A'}, {'start':(11, 9), 'end':(11, 14), 'text':'to create C and EBPbeta1T235A-pRSET-A .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 0), 'end':(12, 7), 'text':'C and EBPbeta1T235A-pRSET-A was digested with HindIII ,'}, {'start':(12, 8), 'end':(12, 12), 'text':'incubated with DNA Polymerase ,'}]}, {'start':(12, 13), 'end':(12, 22), 'text':'and digested with BamHI to isolate C and EBPbeta1T235A .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(13, 0), 'end':(13, 6), 'text':'pcDNA3.1-His-A was digested with BamHI and EcoRV'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 7), 'end':(13, 15), 'text':'and C and EBPbeta1T235A insert was ligated into this'}, {'start':(13, 16), 'end':(13, 22), 'text':'to create C and EBPbeta1T235A-pcDNA 3.1-His-A .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(14, 0), 'end':(14, 9), 'text':'C and EBPbeta1T235A-pcDNA 3.1-His-A was digested with HindIII and XbaI'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 10), 'end':(14, 14), 'text':'and incubated with DNA Polymerase'}, {'start':(14, 15), 'end':(14, 20), 'text':'to isolate T7-C and EBPbeta1T235A .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(15, 0), 'end':(15, 4), 'text':'LZRS-IRES-eGFP was digested with EcoRI'}, {'start':(15, 5), 'end':(15, 10), 'text':'and incubated with DNA Polymerase .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 0), 'end':(16, 9), 'text':'T7-C and EBPbeta1T235A was ligated into LZRS-IRES-eGFP to create LZRS-T7-C'}, {'start':(16, 10), 'end':(16, 12), 'text':'/ EBPbeta1-IRES-eGFP .'}]}, {'start':(17, 0), 'end':(17, 9), 'text':'LZRS-T7-C / EBPbeta2-IRES-eGFP was generated similar to described in .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 0), 'end':(18, 13), 'text':'The only difference being T7-C and EBPbeta2-IRES-eGFP - LZRS was digested with EcoRI ,'}, {'start':(18, 14), 'end':(18, 21), 'text':'incubated with DNA Polymerase , and re-ligated .'}]}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(19, 0), 'end':(19, 9), 'text':'Recombinant amphotropic retroviral stock generation and retroviral infection were performed'}, {'start':(19, 10), 'end':(19, 13), 'text':'as described in .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(20, 0), 'end':(20, 21), 'text':'The pBABE-Ras ( V12 ) - puromycin retroviral construct was a kind gift from Dr. Scott Lowe , Cold Spring Harbor .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(21, 0), 'end':(21, 3), 'text':'Cells were infected once'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 4), 'end':(21, 10), 'text':'and selected with 1ug and mL puromycin'}, {'start':(21, 11), 'end':(21, 23), 'text':'( Sigma Chemical Co. , St. Louis , MO , USA ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 0), 'end':(22, 6), 'text':'Preparation of cell lysates and immunoblot analysis'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(23, 0), 'end':(23, 12), 'text':'Cell lysates were prepared from 100 mm dishes of 90 % confluent cells'}, {'start':(23, 13), 'end':(23, 18), 'text':'as described previously ( ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'LeftToRight', 'children':[{'start':(24, 0), 'end':(24, 19), 'text':'Relative protein concentrations were determined using the Protein Assay Reagent ( BioRad Laboratories , Hercules , CA , USA )'}, {'start':(24, 20), 'end':(24, 25), 'text':'as per manufacturer \'s instructions .'}]}, {'start':(25, 0), 'end':(25, 10), 'text':'Proteins were transferred from the gel to Immobilon P filters .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(26, 0), 'end':(26, 8), 'text':'Immunoblots were processed as previously described ( ) .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(27, 0), 'end':(27, 19), 'text':'The anti-pErk , anti-Erk , anti-cdk2 ( all Santa Cruz Biotechnology , Santa Cruz , CA , USA ) ,'}, {'start':(27, 20), 'end':(27, 38), 'text':'and anti-pcdk2 ( Cell Signaling Technology , Beverly , MA , USA ) antibodies were used at 1:2000 .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(28, 0), 'end':(28, 4), 'text':'Soft agar colony formation assay'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(29, 0), 'end':(29, 14), 'text':'Complete media and 2 % agar ( Difco , Sparks , MD , USA )'}, {'start':(29, 15), 'end':(29, 25), 'text':'were mixed 2:1 to give a 0.7 % agar solution .'}]}]}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(30, 0), 'end':(30, 6), 'text':'This mixture was pipetted into 60mm dishes'}, {'start':(30, 7), 'end':(30, 12), 'text':'to form the bottom layer .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(31, 0), 'end':(31, 2), 'text':'5mL of media'}, {'label':'joint', 'direction':'None', 'children':[{'start':(31, 3), 'end':(31, 14), 'text':'containing 1x10 5 cells was mixed with 2.5 mL 1 % agar'}, {'start':(31, 15), 'end':(31, 21), 'text':'and added as the top layer .'}]}]}, {'start':(32, 0), 'end':(32, 13), 'text':'Cells were fed with media and 1 % agar at a 2:1 ratio .'}]}]}]}]}]}]}]}]}]}
241	242	{'start':(0, 0), 'end':(0, 0), 'text':'1'}
69	144	{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(0, 0), 'end':(0, 0), 'text':'Results'}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 8), 'text':'Ras ( V12 ) negatively regulates C and EBPbeta1'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 9), 'end':(1, 17), 'text':'by causing degradation of C and EBPbeta1 in MCF10As'}, {'start':(2, 0), 'end':(2, 30), 'text':'Expression of all three isoforms of C and EBPbeta is observed via immunoblot of cell lysates from MCF10As , an immortalized yet untransformed MEC line ( , lane 1 ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 17), 'text':'Introduction of Ras ( V12 ) into MCF10As ( MCF10A-Ras ) transforms this cell line ( ) .'}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'contrast', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(4, 0), 'end':(4, 9), 'text':'Examination of C and EBPbeta expression in MCF10A-Ras cells indicates'}, {'start':(4, 10), 'end':(4, 25), 'text':'there is a striking loss of C and EBPbeta1 expression ( , lane 2 ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 0), 'end':(5, 30), 'text':'After observing that introduction of Ras ( V12 ) into MCF10As leads to loss of endogenous C and EBPbeta1 expression , we expressed T7-tagged-C and EBPbeta1 with the retroviral vector LZRS-T7-C'}, {'start':(5, 31), 'end':(5, 33), 'text':'/ EBPbeta1-IRES-eGFP .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 0), 'end':(6, 5), 'text':'Infected cells were sorted by fluorescence'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 6), 'end':(6, 11), 'text':'activated cell sorting ( FACS )'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 12), 'end':(6, 15), 'text':'using green fluorescent protein'}, {'start':(6, 16), 'end':(6, 22), 'text':'( GFP ) as a marker .'}]}]}]}]}]}, {'start':(7, 0), 'end':(7, 18), 'text':'Immediately after sorting , p52-T7-C / EBPbeta1 was expressed in both the MCF10A and MCF10A-Ras cells ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 0), 'end':(8, 12), 'text':'However , T7-C and EBPbeta1 expression three weeks post-sorting is shown in .'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 0), 'end':(9, 17), 'text':'The MCF10A-C and EBPbeta1 cells still expressed p52-T7-C / EBPbeta1 ( , lanes 1 and 3 ; ,'}, {'start':(9, 18), 'end':(9, 21), 'text':'lanes 1-7 ) ,'}]}, {'start':(9, 22), 'end':(9, 31), 'text':'but the MCF10A-Ras-C and EBPbeta1 cells largely lost p52-T7-C /'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 32), 'end':(9, 41), 'text':'EBPbeta1 expression ( , lanes 2 and 4 ; ,'}, {'start':(9, 42), 'end':(9, 45), 'text':'lanes 8-14 ) .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 0), 'end':(10, 25), 'text':'A 31kDa band was observed in the MCF10A-Ras-C and EBPbeta1 cells in the anti-T7 tag immunoblot , indicative of proteolysis ( , Lane 2 ) .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 0), 'end':(11, 23), 'text':'This was confirmed by the presence of 31kDa and 23kDa bands in the anti-C-terminal C and EBPbeta immunoblot ( , Lane 3 ) .'}, {'start':(12, 0), 'end':(12, 21), 'text':'These smaller molecular weight bands were not present in the MCF10A-C and EBPbeta1 cells ( , Lanes 1 and 3 ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'LeftToRight', 'children':[{'start':(13, 0), 'end':(13, 16), 'text':'To determine whether T7-C and EBPbeta1 is being proteolyzed by the proteasome in the MCF10A-Ras cells ,'}, {'start':(13, 17), 'end':(13, 27), 'text':'we treated the cells with MG132 , a proteasomal inhibitor .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 0), 'end':(14, 13), 'text':'Treatment of MCF10A-Ras-C and EBPbeta1 cells with MG132 stabilized expression of p52-T7-CEBPbeta1 ( ,'}, {'start':(14, 14), 'end':(14, 22), 'text':'compare lanes 3 and 4 to 2 ) .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 0), 'end':(15, 12), 'text':'A similar effect was observed upon treatment with lactacystin , another proteasomal inhibitor'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 13), 'end':(15, 14), 'text':'( data'}, {'start':(15, 15), 'end':(15, 18), 'text':'not shown ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 0), 'end':(16, 15), 'text':'Furthermore , treatment of MCF10A-Ras cells with MG132 stabilizes endogenous C and EBPbeta1 ( ) .'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(17, 0), 'end':(17, 4), 'text':'We then wanted to determine'}, {'start':(17, 5), 'end':(17, 15), 'text':'whether degradation of C and EBPbeta1 may be ubiquitin mediated .'}]}]}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(18, 0), 'end':(18, 7), 'text':'MCF10A-Ras-C and EBPbeta1 cells were treated with MG132'}, {'start':(18, 8), 'end':(18, 14), 'text':'and immunoprecipitated with T7-tag antibody beads .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(19, 0), 'end':(19, 6), 'text':'Immunoblot analysis with a Ubiquitin antibody demonstrated'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(19, 7), 'end':(19, 11), 'text':'that MCF10A-Ras-C and EBPbeta1 cells'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(19, 12), 'end':(19, 20), 'text':'treated with MG132 exhibit increased reactivity with this antibody'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(19, 21), 'end':(19, 23), 'text':'compared to controls'}, {'start':(19, 24), 'end':(19, 33), 'text':'( lanes 5 versus lanes 3 and 4 ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(20, 0), 'end':(20, 19), 'text':'Immunoblot analysis of the treated cells with the C and EBPbeta antibody demonstrates a ladder of higher molecular weight bands'}, {'start':(20, 20), 'end':(20, 31), 'text':'that coincide with the molecular weights of bands in the ubiquitin immunoblot'}]}, {'start':(20, 32), 'end':(20, 41), 'text':'( lanes 2 and 5 , see arrows ) ,'}]}, {'start':(20, 42), 'end':(20, 48), 'text':'indicating ubiquitination of C and EBPbeta1 .'}]}, {'start':(21, 0), 'end':(21, 38), 'text':'Most breast cancer cell lines exhibit activation of the Ras pathway through activation of upstream receptors , upregulation of Ras itself , or through activation of downstream signaling molecules ( Melaney and Daly , 2001 , , ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 0), 'end':(22, 11), 'text':'Therefore we expressed T7-C and EBPbeta1 in the breast cancer cell lines'}, {'start':(22, 12), 'end':(22, 22), 'text':'MDA231 and MDA435 in which the Ras pathway is activated .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'LeftToRight', 'children':[{'start':(23, 0), 'end':(23, 26), 'text':'Expression of T7-C and EBPbeta1 in MDA231s and MDA435s decreases over time , similar to the MCF10A-Ras-C and EBPbeta1 cells , and p52-T7-C / EBPbeta1 was stabilized'}, {'start':(23, 27), 'end':(23, 52), 'text':'when MDA231-C and EBPbeta1 and MDA435-C and EBPbeta1 cells were exposed to MG132 ( , lane 3 versus 4 , and data not shown ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(24, 0), 'end':(24, 23), 'text':'Treatment with the cdk inhibitor roscovitine or mutation of C and EBPbeta1 Thr235 to alanine stabilizes expression of T7-C and EBPbeta1 in MCF10A-Ras cells'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(25, 0), 'end':(25, 17), 'text':'Ras ( V12 ) expression in the MCF10A-Ras cells may lead to phosphorylation of C and EBPbeta1 ,'}, {'start':(25, 18), 'end':(25, 27), 'text':'which is subsequently causing degradation of C and EBPbeta1 .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(26, 0), 'end':(26, 4), 'text':'To further investigate the mechanism'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(26, 5), 'end':(26, 25), 'text':'by which Ras negatively regulates C and EBPbeta1 , MCF10A-Ras-C and EBPbeta1 cells were treated with a panel of kinase inhibitors'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(26, 26), 'end':(26, 28), 'text':'that inhibit kinases'}, {'start':(26, 29), 'end':(26, 35), 'text':'known to phosphorylate C and EBPbeta .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(27, 0), 'end':(27, 9), 'text':'Treatment with the cdk inhibitor roscovitine stabilized expression of p52-T7-C'}, {'start':(27, 10), 'end':(27, 13), 'text':'/ EBPbeta1 ( ,'}]}, {'start':(27, 14), 'end':(27, 20), 'text':'compare lanes 2 and 4 ) .'}]}, {'start':(28, 0), 'end':(28, 9), 'text':'C and EBPbeta is phosphorylated on Thr235 by cdk2 .'}]}]}]}]}]}]}]}]}, {'start':(29, 0), 'end':(29, 17), 'text':'More specifically , C and EBPbeta1 can be phosphorylated on Thr235 by cdk2 in vitro ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(30, 0), 'end':(30, 12), 'text':'This phosphorylation can be inhibited by treatment with roscovitine ( , , data'}, {'start':(30, 13), 'end':(30, 16), 'text':'not shown ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(31, 0), 'end':(31, 6), 'text':'Treatment with roscovitine was the only treatment'}, {'start':(31, 7), 'end':(31, 17), 'text':'that stabilized expression of p52-T7-C / EBPbeta1 in MCF10A-Ras cells .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(32, 0), 'end':(32, 12), 'text':'Treatment of MDA231-C and EBPbeta1 cells with roscovitine also stabilized expression of p52-T7-C'}, {'start':(32, 13), 'end':(32, 20), 'text':'/ EBPbeta1 ( data not shown ) .'}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(33, 0), 'end':(33, 12), 'text':'Importantly , cdk2 is activated in MCF10A-Ras and MDA231 cells ( ) .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(34, 0), 'end':(34, 24), 'text':'To confirm that phosphorylation by cdk2 on C and EBPbeta1-Thr 235 was leading to degradation of C and EBPbeta1 , Thr235 was mutated to alanine'}, {'start':(34, 25), 'end':(34, 27), 'text':'( T235A )'}]}, {'start':(34, 28), 'end':(34, 36), 'text':'so this residue could no longer be phosphorylated .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(35, 0), 'end':(35, 7), 'text':'An LZRS-T7-C / EBPbeta1T235A-IRES-eGFP retroviral vector was constructed'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(35, 8), 'end':(35, 11), 'text':'and the resulting retrovirus'}, {'start':(35, 12), 'end':(35, 17), 'text':'used to infect MCF10A-Ras cells .'}]}]}]}]}, {'start':(36, 0), 'end':(36, 11), 'text':'These cells were sorted by FACS using GFP as a marker .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(37, 0), 'end':(37, 9), 'text':'Mutation of Thr235 to alanine in C and EBPbeta1 ,'}, {'start':(37, 10), 'end':(37, 18), 'text':'thus preventing phosphorylation of this residue by cdk2 ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(37, 19), 'end':(37, 32), 'text':'stabilized the expression of p52-T7-C / EBPbeta1 after three weeks in culture ( ,'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(37, 33), 'end':(37, 37), 'text':'lane 3 versus 6 )'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(37, 38), 'end':(37, 43), 'text':'as compared to T7-C and EBPbeta1'}, {'start':(37, 44), 'end':(37, 57), 'text':'that did not contain this mutation ( , lane 2 versus 5 ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(38, 0), 'end':(38, 20), 'text':'T7-C and EBPbeta1 and T7-C and EBPbeta1T235A expression did not have an effect on the transformed phenotype of MCF10A-Ras cells ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(38, 21), 'end':(38, 25), 'text':'as these cells \' ability'}, {'start':(38, 26), 'end':(38, 36), 'text':'to form colonies in soft agar was unaltered ( ) .'}]}]}, {'label':'explanation', 'direction':'LeftToRight', 'children':[{'start':(39, 0), 'end':(39, 16), 'text':'T7-C and EBPbeta1 and T7-C and EBPbeta1T235A are unable to induce senescence in MCF10A cells in part'}, {'start':(39, 17), 'end':(39, 27), 'text':'because these cells have the p14ARF/p15INK4B/p16INK4A locus deleted ( ) .'}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(40, 0), 'end':(40, 23), 'text':'p16INK4A is an important player in OIS , and C and EBPbeta induced senescence signals through this tumor suppressor during OIS ( ) .'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(41, 0), 'end':(41, 15), 'text':'Additionally , C and EBPbeta has been shown to induce p15INK4B during OIS ( ) .'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(42, 0), 'end':(42, 7), 'text':'C and EBPbeta1 is not degraded upon Ras'}, {'start':(42, 8), 'end':(42, 15), 'text':'( V12 ) introduction into WI-38 normal HDFs'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(43, 0), 'end':(43, 12), 'text':'Recently , C and EBPbeta has been shown to be essential for Ras'}, {'start':(43, 13), 'end':(43, 31), 'text':'( V12 ) - and Raf ( E600 ) - induced senescence in MEFs and HDFs , respectively .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(44, 0), 'end':(44, 3), 'text':'We decided to determine'}, {'start':(44, 4), 'end':(44, 16), 'text':'which isoform of C and EBPbeta is responsible for induction of senescence .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(45, 0), 'end':(45, 1), 'text':'We hypothesized'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(45, 2), 'end':(45, 2), 'text':'that'}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(45, 3), 'end':(45, 9), 'text':'since Ras negatively regulates C and EBPbeta1'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(45, 10), 'end':(45, 18), 'text':'by leading to its degradation during Ras transformation ,'}, {'start':(45, 19), 'end':(45, 33), 'text':'that this full length isoform of C and EBPbeta is responsible for inducing senescence .'}]}]}]}]}, {'label':'contrast', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(46, 0), 'end':(46, 5), 'text':'First , we wanted to determine'}, {'start':(46, 6), 'end':(46, 13), 'text':'if introduction of Ras ( V12 ) ,'}]}, {'start':(46, 14), 'end':(46, 19), 'text':'and thus induction of senescence ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(46, 20), 'end':(46, 30), 'text':'negatively regulates C and EBPbeta1 expression in normal HDFs , cells'}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(46, 31), 'end':(46, 32), 'text':'commonly used'}, {'start':(46, 33), 'end':(46, 36), 'text':'to study senescence .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(47, 0), 'end':(47, 19), 'text':'is an immunoblot with an antibody specific for the N-terminal 23 amino acids present only in C and EBPbeta1 .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(48, 0), 'end':(48, 2), 'text':'This immunoblot demonstrates'}, {'start':(48, 3), 'end':(48, 29), 'text':'that Ras ( V12 ) does not lead to degradation of C and EBPbeta1 in the normal WI-38 cells ( , lanes 2 and 3 ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(49, 0), 'end':(49, 8), 'text':'C and EBPbeta1 expression in WI-38 cells inhibits growth'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(50, 0), 'end':(50, 3), 'text':'Next , we tested'}, {'start':(50, 4), 'end':(50, 19), 'text':'whether exogenous expression of C and EBPbeta1 had an effect on growth of normal fibroblasts .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(51, 0), 'end':(51, 5), 'text':'We performed a colony formation assay'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(51, 6), 'end':(51, 12), 'text':'using uninfected WI-38 cells or WI-38 cells'}, {'label':'joint', 'direction':'None', 'children':[{'start':(51, 13), 'end':(51, 19), 'text':'infected with LZRS-T7-C / EBPbeta1-IRES-eGFP or LZRS-eGFP'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(51, 20), 'end':(51, 23), 'text':'and sorted by FACs'}, {'start':(51, 24), 'end':(51, 29), 'text':'using GFP as a marker .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(52, 0), 'end':(52, 3), 'text':'As shown in ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(52, 4), 'end':(52, 11), 'text':'there were significantly fewer WI-38-T7-C / EBPbeta1 colonies'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(52, 12), 'end':(52, 14), 'text':'compared to controls'}, {'start':(52, 15), 'end':(52, 20), 'text':'( p = 0.007 ) ,'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(52, 21), 'end':(52, 30), 'text':'indicating T7-C and EBPbeta1 expression in WI-38 cells inhibits growth'}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(52, 31), 'end':(52, 36), 'text':'and is potentially causing these cells'}, {'start':(52, 37), 'end':(52, 39), 'text':'to senesce .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(53, 0), 'end':(53, 4), 'text':'To confirm these findings ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(53, 5), 'end':(53, 12), 'text':'we performed a bromodeoxyuridine ( Brdu ) assay'}, {'label':'joint', 'direction':'None', 'children':[{'start':(53, 13), 'end':(53, 17), 'text':'using uninfected WI-38 cells ,'}, {'label':'attribution', 'direction':'LeftToRight', 'children':[{'start':(53, 18), 'end':(53, 31), 'text':'or sorted WI-38 cells expressing T7-C and EBPbeta1 and GFP or GFP only ,'}, {'start':(53, 32), 'end':(53, 35), 'text':'as shown in .'}]}]}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(54, 0), 'end':(54, 11), 'text':'The WI-38-T7-C / EBPbeta1 cells have significantly less Brdu staining than controls'}, {'start':(54, 12), 'end':(54, 17), 'text':'( p = 0.027 ) ,'}]}, {'start':(54, 18), 'end':(54, 33), 'text':'confirming the results from that C and EBPbeta1 expression in WI-38 cells inhibits their proliferation .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(55, 0), 'end':(55, 7), 'text':'C and EBPbeta1 induces IL6 in WI-38 fibroblasts'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(56, 0), 'end':(56, 3), 'text':'reported that activated Raf'}, {'start':(56, 4), 'end':(56, 20), 'text':'( E600 ) - induced senescence in HDFs is due to activation of an inflammatory transcriptome .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(57, 0), 'end':(57, 3), 'text':'This elegant study demonstrated'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(57, 4), 'end':(57, 6), 'text':'that activated Raf'}, {'start':(57, 7), 'end':(57, 22), 'text':'( E600 ) - induced senescence was dependent upon IL6 activation by C and EBPbeta .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(58, 0), 'end':(58, 2), 'text':'Thus we examined'}, {'start':(58, 3), 'end':(58, 16), 'text':'if a specific transactivator isoform of C and EBPbeta was inducing IL6 expression .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(59, 0), 'end':(59, 8), 'text':'RNA was prepared six days posti-infection from WI-38 cells'}, {'start':(59, 9), 'end':(59, 28), 'text':'infected with LZRS-T7-C / EBPbeta1-IRES-eGFP , LZRS-T7-C / EBPbeta2-IRES-eGFP , LZRS-GFP , or pBABE-Ras ( V12 ) - puromycin .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(60, 0), 'end':(60, 5), 'text':'cDNA was prepared from the RNA'}, {'start':(60, 6), 'end':(60, 14), 'text':'and qPCR was performed using an IL6 primer .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(61, 0), 'end':(61, 9), 'text':'T7-C and EBPbeta1-WI -38 cells and the positive control Ras'}, {'start':(61, 10), 'end':(61, 25), 'text':'( V12 ) - expressing cells highly upregulate IL6 RNA 6.6 fold and 8 fold ,'}]}, {'start':(61, 26), 'end':(61, 29), 'text':'respectively ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(62, 0), 'end':(62, 25), 'text':'T7-C and EBPbeta2 only induces IL6 expression 2.1 fold compared to uninfected cells despite approximately equal levels of T7-C and EBPbeta1 and T7-C and EBPbeta2 protein'}, {'start':(62, 26), 'end':(62, 33), 'text':'being expressed on day 6 ( ) .'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(63, 0), 'end':(63, 3), 'text':'C and EBPbeta1 ,'}, {'start':(63, 4), 'end':(63, 12), 'text':'and to a lesser extent C and EBPbeta2 ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(63, 13), 'end':(63, 17), 'text':'induces senescence in WI-38 HDFs'}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(64, 0), 'end':(64, 16), 'text':'Knowing that C and EBPbeta1 induces IL6 to a much greater level than C and EBPbeta2 ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(64, 17), 'end':(64, 18), 'text':'we determined'}, {'start':(64, 19), 'end':(64, 28), 'text':'if C and EBPbeta1 could cause senescence more effectively .'}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(65, 0), 'end':(65, 19), 'text':'WI-38 cells infected with LZRS-T7-C / EBPbeta1-IRES-eGFP , LZRS-T7-C / EBPbeta2-IRES-eGFP , LZRS-GFP , or pBABE-Ras ( V12 ) -'}, {'label':'joint', 'direction':'None', 'children':[{'start':(65, 20), 'end':(65, 22), 'text':'puromycin were fixed'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(65, 23), 'end':(65, 26), 'text':'and stained for senescence'}, {'start':(65, 27), 'end':(65, 34), 'text':'associated beta-galactosidase six days post-infection ( ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(66, 0), 'end':(66, 21), 'text':'On average , over 53 % of the T7-C and EBPbeta1-WI -38 cells and over 55 % of the positive control Ras'}, {'start':(66, 22), 'end':(66, 32), 'text':'( V12 ) - WI-38 cells stained a bright blue ,'}]}, {'start':(66, 33), 'end':(66, 44), 'text':'compared to 34.5 % of the T7-C and EBPbeta2 expressing cells .'}]}, {'start':(67, 0), 'end':(67, 14), 'text':'Less than 20 % of control uninfected or LZRS-GFP cells stained a faint blue .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(68, 0), 'end':(68, 18), 'text':'A statistically significant difference in blue staining exists between the T7-C and EBPbeta1- and Ras ( V12 ) -'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(68, 19), 'end':(68, 24), 'text':'expressing WI-38 cells versus uninfected ,'}, {'start':(68, 25), 'end':(68, 36), 'text':'resulting in p values 0.005 and 0.003 , respectively ( ) .'}]}]}]}, {'label':'background', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(69, 0), 'end':(69, 8), 'text':'This is consistent with T7-C and EBPbeta1 expressing cells'}, {'start':(69, 9), 'end':(69, 10), 'text':'inhibiting growth'}]}, {'start':(69, 11), 'end':(69, 14), 'text':'as shown earlier .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(70, 0), 'end':(70, 38), 'text':'Although the T7-C and EBPbeta2 cells induced senescence to a lesser extent than T7-C and EBPbeta1 , the percentage of blue cells was still statistically significant as compared to uninfected cells , with a p value of 0.03 .'}, {'start':(71, 0), 'end':(71, 15), 'text':'Approximately equal levels of T7-C and EBPbeta1 and T7-C and EBPbeta2 were expressed ( ) .'}]}]}, {'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(72, 0), 'end':(72, 4), 'text':'To confirm these findings ,'}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(72, 5), 'end':(72, 10), 'text':'p16INK4A protein levels were examined ,'}, {'start':(72, 11), 'end':(72, 17), 'text':'as p16INK4A is upregulated during senescence .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(73, 0), 'end':(73, 23), 'text':'WI-38 cells were uninfected , infected with LZRS-T7-C / EBPbeta1-IRES-eGFP , LZRS-T7-C / EBPbeta2-IRES-eGFP or LZRS-GFP , cell lysates were prepared 6 days post-infection'}, {'start':(73, 24), 'end':(73, 32), 'text':'and immunoblot analysis was performed for p16INK4A expression .'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(74, 0), 'end':(74, 0), 'text':'indicates'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(74, 1), 'end':(74, 16), 'text':'that C and EBPbeta1 and C and EBPbeta2 expression in WI-38 cells induces p16INK2A expression ,'}, {'start':(74, 17), 'end':(74, 22), 'text':'verifying the induction of senescence .'}]}]}]}]}]}]}]}]}]}]}
242	243	{'start':(0, 0), 'end':(0, 0), 'text':'2'}
244	245	{'start':(0, 0), 'end':(0, 0), 'text':'Figures'}
